Top Startup and Tech Funding News – August 14, 2025

It’s Thursday, August 14, 2025, and we’re back with today’s top startup and tech funding news from across the globe. From enterprise AI platforms and heart failure devices to stablecoin payment rails and rare disease data networks, today’s deals show no signs of easing. If anything, the capital is chasing conviction bets—targeting AI-driven automation, healthcare breakthroughs, and fintech infrastructure plays with long-term defensibility.

From Toronto’s AI labs to Estonia’s medtech corridors, today’s rounds span every stage—from stealth-mode early seeds to late-stage mega-raises. And with investors ranging from sovereign wealth funds to specialized healthcare VCs stepping up, the message is clear: the right teams with the right thesis are still getting funded—and funded big.

Funding Highlights

Cohere led the day with a $500 million raise to push enterprise AI deeper into the corporate stack, while Titan secured $74 million to reimagine IT services with AI at its core. In healthtech, Reprieve Cardiovascular closed $61 million for its personalized heart failure therapy, Arbital Health took in $31 million to streamline value-based care, and Citizen Health banked $30 million to scale its rare disease platform. Fintech saw action with Transak’s $16 million to grow global stablecoin payment rails, while home services SaaS Topline Pro raised $27 million to help skilled trades win more business.

Early-stage momentum came from Sola ($21 M) and Create ($8.5 M) in AI automation and app building, alongside Parag Agrawal’s stealth venture ($30 M) targeting AI agent infrastructure. Internationally, Estonia’s Better Medicine secured €6 million to boost AI cancer detection.

Investor Activity

The capital came from all corners—Radical Ventures, Inovia, General Catalyst, Deerfield, 8VC, Northzone, and Tether—signaling a strong mix of tech-heavy funds and sector specialists. Whether in AI agents, health data platforms, or next-gen payments, today’s rounds underline that founders aren’t waiting for the market to thaw—they’re building into the future.

Here’s the full rundown:

Cohere Raises $500M in Funding to Scale Enterprise AI at $6.8B Valuation

Cohere, a Toronto-based generative AI startup, has pulled in a massive $500 million in new funding to accelerate its push into enterprise AI solutions. The latest round values Cohere at $6.8 billion, up sharply from $5.5 billion last year. Founded in 2019 by ex-Google researchers, Cohere provides cloud-agnostic large language models and AI agents tailored for businesses and governments.

The fresh cash infusion, one of the year’s largest AI funding rounds, will fuel Cohere’s global expansion and R&D as it competes with OpenAI and Anthropic in the booming enterprise AI market. The company has roughly $1.5 billion in total funding to date, reflecting investors’ confidence in its ability to win corporate AI adoption.

Funding Details:

• Startup: Cohere (Toronto, Canada – Enterprise AI platform)

• Investors: Radical Ventures and Inovia Capital (co-leads); joined by Nvidia, AMD Ventures, PSP Investments, Salesforce Ventures, and Healthcare of Ontario Pension Plan (HOOPP).

• Amount Raised: $500 million

• Total Raised: ~$1.5 billion

• Funding Stage: Late-stage (Private funding round)

• Funding Date: August 14, 2025

Titan Secures $74M in Funding to Build AI-Driven IT Services Platform

Titan, a New York City-based IT services company, raised $74 million to expand its augmented AI platform for managed service providers (MSPs). The round was led by General Catalyst, underscoring strong backing for Titan’s strategy of combining human expertise with AI to modernize IT support.

Founded by seasoned industry operators, Titan has been quietly rolling up MSP capabilities – even announcing the acquisition of RFA, a financial-sector MSP, alongside this funding. With Titan’s AI platform layered into RFA’s operations, the company aims to deliver faster, more proactive tech support without losing the high-touch service clients expect. This new capital will help Titan scale its platform and pursue further growth opportunities as it seeks to transform traditional IT services through AI.

Funding Details:

• Startup: Titan (New York, USA – AI-powered IT services platform)

• Investors: General Catalyst (lead); other participating investors not disclosed.

• Amount Raised: $74 million

• Total Raised: Not disclosed (new venture with significant initial financing)

• Funding Stage: Growth funding (Private round)

• Funding Date: August 14, 2025

Reprieve Cardiovascular Lands $61M in Series B Funding for Heart Failure Device

Reprieve Cardiovascular, a Milford, MA-based medical device startup, has secured $61 million in Series B financing to advance its novel therapy for acute heart failure. The oversubscribed round was led by Deerfield Management and joined by healthcare-focused funds including Arboretum, Lightstone, Sante, and Rex Health Ventures. Reprieve is developing a system to precisely remove excess fluid and sodium in hospitalized heart failure patients, aiming to personalize diuretic therapy and improve outcomes.

The new funding will support a pivotal FASTR II clinical trial enrolling 400 patients to compare Reprieve’s device against standard care. Proceeds will also prepare Reprieve for commercialization, as the company works toward FDA approval of its fluid management system. The latest raise brings Reprieve’s total funding to over $100 million (it previously raised $42 million in Series A last year), giving it ample runway to tackle a major unmet need in heart failure treatment.

Funding Details:

• Startup: Reprieve Cardiovascular (Massachusetts, USA – Medtech for heart failure)

• Investors: Deerfield Management (lead); Rex Health Ventures (UNC Health), Arboretum Ventures, Lightstone Ventures, Sante Ventures, Genesis Capital, Cadence Capital, plus an undisclosed strategic investor.

• Amount Raised: $61 million

• Total Raised: ~$103 million

• Funding Stage: Series B

• Funding Date: August 14, 2025

Arbital Health Secures $31M in Series B Funding to Streamline Value-Based Care

Arbital Health, a San Francisco-based healthtech startup, raised $31 million in Series B funding to scale its platform for managing value-based care contracts. The round was led by Valtruis (a VC firm focused on value-based care) with participation from existing backers Transformation Capital, Shaper Capital, and Healthy Ventures. Arbital provides an AI-powered analytics and infrastructure platform that helps healthcare providers and insurers reconcile and optimize risk-sharing agreements in real time.

By combining advanced software with a team of top healthcare actuaries, Arbital aims to simplify the complexity of outcomes-based reimbursement models. The new funding will expand Arbital’s product capabilities for payers and providers and grow its actuarial and data science team to meet rising demand. Founded in 2024, Arbital has already onboarded 40+ healthcare organizations and 600,000 patient lives to its system, addressing the urgent need for tools that align financial incentives with patient outcomes in the healthcare industry.

Funding Details:

• Startup: Arbital Health (California, USA – Value-based care analytics platform)

• Investors: Valtruis (lead); Transformation Capital, Shaper Capital, Healthy Ventures (existing investor).

• Amount Raised: $31 million

• Total Raised: Not disclosed (~$45 million estimated, including prior Series A)

• Funding Stage: Series B

• Funding Date: August 14, 2025

Citizen Health Scores $30M in Series A Funding to Advance Rare Disease Platform

Citizen Health, a San Francisco-based healthcare platform focused on rare diseases, announced a $30 million Series A to expand its patient-centered approach to rare disease care. The round was led by 8VC, with participation from Transformation Capital and Headline. Launched in late 2023, Citizen Health combines AI tools, community data sharing, and patient advocacy to help those with rare conditions navigate care and accelerate research.

Citizen Health enables patients to contribute to a rich longitudinal dataset – aligning with recent FDA calls for innovation in rare disease – while empowering them to take control of their care. Citizen Health will use the new funding to grow its operations and R&D, enhancing the platform’s capabilities and support programs. This Series A brings the company’s total financing to $44 million since its inception, providing a solid foundation to tackle the high unmet needs in the rare disease community.

Funding Details:

• Startup: Citizen Health (California, USA – Patient-powered rare disease platform)

• Investors: 8VC (lead); Transformation Capital, Headline.

• Amount Raised: $30 million

• Total Raised: $44 million

• Funding Stage: Series A

• Funding Date: August 14, 2025

Ex-Twitter CEO Parag Agrawal’s New Startup Gets $30M in Funding to Build AI for Web Search

Parallel (working name), the stealthy AI startup co-founded by former Twitter CEO Parag Agrawal, has raised about $30 million as it emerges from secrecy. According to Bloomberg, Agrawal’s new venture is building infrastructure for AI agents to browse and interact with the web – essentially creating tools that let AI models search the internet more efficiently. The company’s initial funding was led by Khosla Ventures and joined by a handful of other investors.

With a 25-person team already in place, Parallel is targeting the growing need for AI “agent” systems that can perform autonomous tasks online. Agrawal describes the AI agents themselves as the target customers, hinting that Parallel’s technology will serve as a backend for various AI applications that need up-to-date web information. The fresh $30M infusion gives Parallel a substantial runway to build out this AI agent infrastructure as it officially launches. (Note: The startup’s formal name was not disclosed; “Parallel” is a project name.)

Funding Details:

• Startup: “Parallel” (Unofficial name – Silicon Valley, USA – AI agents web infrastructure)

• Investors: Khosla Ventures (lead); others undisclosed

• Amount Raised: $30 million

• Total Raised: $30 million (first funding round)

• Funding Stage: Seed / Series A (early-stage)

• Funding Date: August 14, 2025

Sola Raises $21M in Seed and Series A Funding to Automate Work with AI Agents

Sola, an enterprise AI startup founded by two MIT dropouts, has emerged from stealth with $21 million in combined seed and Series A funding. The company is building AI agent software to automate repetitive back-office tasks for legacy industries, effectively acting as “virtual employees” for grunt work. Sola’s funding includes a $3.5 million seed round led by Conviction and a $17.5 million Series A led by Andreessen Horowitz (a16z).

With these funds, the Boston-based startup (named “Sola”) plans to scale development of its AI agents and pilot them with enterprise customers bogged down by manual processes. By offloading routine tasks to AI, Sola aims to free up human workers for higher-value work and help older businesses modernize. The involvement of a16z – one of Silicon Valley’s top VC firms – signals confidence in Sola’s vision to bring AI automation to the enterprise. The company’s total funding now stands at $21M, earmarked to grow the team and refine the product for wider deployment.

Funding Details:

• Startup: Sola (Massachusetts, USA – AI agents for automating business tasks)

• Investors: Andreessen Horowitz (lead, Series A); Conviction (lead, seed); and other angel investors.

• Amount Raised: $21 million (aggregate of seed + Series A)

• Total Raised: $21 million

• Funding Stage: Series A (with prior Seed)

• Funding Date: August 14, 2025

Topline Pro Secures $27M in Series B Funding to Boost AI for Home Services

Topline Pro, a New York City-based SaaS startup, has raised $27 million in Series B funding to help home service businesses grow using AI. The round was led by Northzone (with partner Molly Alter) and joined by new and existing investors, including Tactile, Forerunner, Bonfire, Flybridge, TMV, and BBG Ventures. Topline Pro offers an AI-powered platform for small home service contractors – think plumbers, landscapers, painters – to automate their online presence, from building websites and managing SEO to handling customer messaging and payments.

Essentially acting as a digital marketing and operations assistant, Topline’s tools have helped thousands of “pros” generate over $650 million in bookings to date. The startup will use the new capital to accelerate product development and expand into more markets. With this Series B, Topline Pro’s total funding climbs above $35 million. The fresh funds will enable Topline to continue bringing modern, AI-driven business support to the often-overlooked skilled trades and home services sector.

Funding Details:

• Startup: Topline Pro (New York, USA – AI platform for home service businesses)

• Investors: Northzone (lead); Tactile Ventures, Industry Ventures, Forerunner Ventures, Bonfire Ventures, TMV, Flybridge, BBG Ventures.

• Amount Raised: $27 million

• Total Raised: ~$35 million

• Funding Stage: Series B

• Funding Date: August 14, 2025

Transak Raises $16M in Funding to Expand Global Stablecoin Payments Infrastructure

Transak, a Miami-based fintech startup, raised $16 million to scale its fiat-to-crypto payments infrastructure. The funding round was led by Tether and IDG Capital, with participation from a roster of crypto-focused investors including Primal Capital, 1kx, Protein Capital, KX VC, and others.

Transak provides a unified API that enables developers to embed fiat-to-stablecoin on-ramps in their apps, supporting local payment methods across 75+ countries. Essentially, Transak is building the rails for stablecoin-powered payments, allowing users worldwide to convert between traditional currency and crypto stablecoins seamlessly. The startup has processed over $2 billion in transactions so far, and it holds regulatory approvals in the US, UK, EU, Canada, Australia, and India.

With the new funding, Transak will expand its stablecoin payments stack, grow into new markets, and double down on compliance and partnerships. This raise brings Transak’s total disclosed funding to date to around $20 million, strengthening its position as a key player in the global crypto payments infrastructure space.

Funding Details:

• Startup: Transak (Florida, USA – Fiat-to-crypto payments API for stablecoins)

• Investors: Tether and IDG Capital (co-leads); joined by Primal Capital, 1kx, Protein Capital, CEiC, KX VC, 3KVC, Genting Ventures, Fuel Ventures, and Umami Capital.

• Amount Raised: $16 million

• Total Raised: ~$20 million

• Funding Stage: Series A / Private round

• Funding Date: August 14, 2025

Create (“Anything” Platform) Nabs $8.5M in Funding to Democratize App Development with AI

Create, a San Francisco-based startup behind the AI coding agent “Anything,” has raised $8.5 million in total funding to date, including a new $5.5 million round led by Bessemer Venture Partners. The company’s platform allows anyone to generate fully functional apps from a simple idea description, handling everything from front-end design to back-end hosting automatically.

Create’s flagship product, Anything, went viral after launch – attracting 3.2 million views and 30,000 signups in 72 hours – which helped convince top investors. In addition to Bessemer, notable angel backers include Shopify founder Tobi Lütke and the CEOs of Front, Zapier, and Intercom.

With its “app generator” AI now in demand, Create will use the funds to scale its platform to serve more users (including agencies and enterprises) and expand features like monetization tools. By eliminating the technical barriers to app creation, Create aims to become the “Shopify for software,” enabling a new wave of entrepreneurs to launch apps as easily as selling products online.

Funding Details:

• Startup: Create (California, USA – AI-powered app development platform)

• Investors: Bessemer Venture Partners (lead); and prominent angels including Tobi Lütke (Shopify), Mathilde Collin (Front), Wade Foster (Zapier), Des Traynor (Intercom), Laura Wu (Shippo), and Ben Tossell (Ben’s Bites).

• Amount Raised: $8.5 million (total funding to date)

• Total Raised: $8.5 million

• Funding Stage: Seed / Early-stage

• Funding Date: August 14, 2025

Better Medicine Raises €6M in Funding to Tackle Radiologist Shortages with AI

Better Medicine, an Estonian healthtech startup, has raised a total of €6 million (approx. $6.5M) in combined funding and grants to develop its AI-powered cancer detection tools. The company just closed a €1 million pre-seed round led by Soulmates Ventures, joined by Specialist VC, UT Ventures, and angel investors. This follows a €2.5 million grant earlier this year from the European Innovation Council, bringing Better Medicine’s total capital to ~€6M when including non-dilutive funding.

Founded in 2020 in Tartu, the startup addresses a global radiologist shortage by using deep learning to analyze medical scans for malignancies. Its first product, BMVision Kidney, can detect kidney tumors in CT scans with 99% accuracy and has earned CE certification under the EU’s new medical device regulations. In trials, radiologists using Better Medicine’s AI saw workflow time cut in half.

The new funds will help Better Medicine roll out its tools across Europe, expand into detecting other cancers, and prepare for U.S. FDA clearance. By automating tedious image analysis, the company aims to boost early cancer detection and relieve overburdened radiology departments worldwide.

Funding Details:

• Startup: Better Medicine (Tartu, Estonia – AI diagnostics for radiology)

• Investors: Soulmates Ventures (lead); Specialist VC, University of Tartu (UT) Ventures, and angel investors. Plus: €2.5M grant from European Innovation Council.

• Amount Raised: €1 million equity + €5 million in grants/other funding (≈ €6 million total)

• Total Raised: €6 million (including grants)

• Funding Stage: Pre-Seed

• Funding Date: August 14, 2025

After an eventful day of funding news, here is a Tech Funding Summary Table recapping all the startups, investors, and round details from August 14, 2025:

Tech Funding Summary Table